Your browser doesn't support javascript.
loading
A new prognostic index to make short-term prognoses in MDS patients treated with azacitidine: A combination of p53 expression and cytogenetics.
Nishiwaki, Satoshi; Ito, Masafumi; Watarai, Rie; Okuno, Shingo; Harada, Yasuhiko; Yamamoto, Satomi; Suzuki, Kotaro; Kurahashi, Shingo; Iwasaki, Toshihiro; Sugiura, Isamu.
Afiliação
  • Nishiwaki S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan. Electronic address: n-3104@tf7.so-net.ne.jp.
  • Ito M; Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Watarai R; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Okuno S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Harada Y; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Yamamoto S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Suzuki K; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Iwasaki T; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Sugiura I; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
Leuk Res ; 41: 21-6, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26651421

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Antimetabólitos Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Azacitidina / Síndromes Mielodisplásicas / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Antimetabólitos Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2016 Tipo de documento: Article